Published by: Area9 LyceumMar 10, 2022 4:34:00 PM

Therapeutic Inertia in Type 2 Diabetes

Learn about cardiorenal risk in people with T2D
Discover if SGLT2i and GLP-1 RA protect against renal events
Understand therapeutic inertia
Cultivate solutions in clinical practice
Advocate for patient education and empowerment

Recent Posts

eLearning AWARD 2023 in the category "AI" goes to Sky Germany and Area9 Lyceum

The Australian Institute of Health and Safety (AIHS), John Holland and Area9 Lyceum have entered a partnership to bring adaptive learning technology to the construction sector

Listen in to the latest Leaders Learns Podcast with Area9 Lyceum´s CEO, Ulrik Juul Christensen, on how to build a learning culture that improves retention

John Holland has seen the benefits of Area9 Lyceum’s Rhapsode as their new health and safety learning platform

FORBES FEATURE: Learning - A New Corporate Responsibility by Area9 Lyceum’s CEO Ulrik Juul Christensen and Gajen Kandiah, CEO of Hitachi

eLearning AWARD 2023 in the category "AI" goes to Sky Germany and Area9 Lyceum

The Australian Institute of Health and Safety (AIHS), John Holland and Area9 Lyceum have entered a partnership to bring adaptive learning technology to the construction sector

Listen in to the latest Leaders Learns Podcast with Area9 Lyceum´s CEO, Ulrik Juul Christensen, on how to build a learning culture that improves retention

John Holland has seen the benefits of Area9 Lyceum’s Rhapsode as their new health and safety learning platform